IndraLab

Statements


MYSM1 inhibits miR-200. 2 / 2
| 2

reach
"MYSM1 inhibited the CRC progression via miR-200/CDH1 and inhibition of PI3K/AKT axis [35]."

reach
"MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling."